11 – 20 of 27
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Identification of a Danger-Associated Peptide From Apolipoprotein B100 (ApoBDS-1) That Triggers Innate Proatherogenic Responses
(
- Contribution to journal › Article
-
Mark
Immunization of apoE-/- mice with aldehyde-modified fibronectin inhibits the development of atherosclerosis.
(
- Contribution to journal › Article
- 2010
-
Mark
The pro-inflammatory effect of uraemia overrules the anti-atherogenic potential of immunization with oxidized LDL in apoE-/- mice
(
- Contribution to journal › Article
-
Mark
Intranasal Immunization With an Apolipoprotein B-100 Fusion Protein Induces Antigen-Specific Regulatory T Cells and Reduces Atherosclerosis
(
- Contribution to journal › Article
- 2007
-
Mark
Inhibition of injury-induced arterial remodelling and carotid atherosclerosis by recombinant human antibodies against aldehyde-modified apoB-100.
(
- Contribution to journal › Article
-
Mark
Association between IgM against an aldehyde-modified peptide in apolipoprotein B-100 and progression of carotid disease
(
- Contribution to journal › Article
-
Mark
Autoimmune responses against the apo B-100 LDL receptor-binding site protect against arterial accumulation of lipids in LDL receptor deficient mice.
(
- Contribution to journal › Article
-
Mark
Medial Expression of TNF-α and TNF Receptors Precedes the Development of Atherosclerotic Lesions in Apolipoprotein E/LDL Receptor Double Knockout Mice
(
- Contribution to journal › Article
- 2006
-
Mark
Identification of autoantibodies in human plasma recognizing an apoB-100 LDL receptor binding site peptide
(
- Contribution to journal › Article
-
Mark
Oxidized lipoprotein autoimmunity: an emerging drug target in cardiovascular disease
(
- Contribution to journal › Scientific review